Minority Powerbrokers Q&A: Sterne Kessler's Dr. Longsworth
Law360, New York ( January 14, 2015, 1:37 PM EST) -- Gaby L. Longsworth, Ph.D., is a director in the biotechnology and chemical group at Sterne Kessler Goldstein & Fox PLLC, an intellectual property law firm in Washington, D.C. Dr. Longsworth advises both innovator and generic biotech and pharmaceutical companies on IP and product lifecycle management strategies. A large part of her practice is focused on representing international and domestic generic pharmaceutical companies in patent cases involving abbreviated new drug applications that include a Paragraph IV certification to one or more Orange Book-listed patents. She also uses her generic drug experience to counsel innovator pharmaceutical companies throughout the world in all areas of patent procurement, including domestic and foreign patent preparation, and lifecycle management strategies....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.